South Korea
· Delayed Price · Currency is KRW Kyongbo Pharmaceutical Company Description
Kyongbo Pharmaceutical Co., Ltd manufactures and sells active pharmaceutical ingredients and finished drugs in South Korea and internationally.
The company offers general, cephalosporins, and anti-cancer APIs; prescription drugs, including anesthetic, cardiovascular, digestive, and antibiotics; and OTC drugs.
It also provides medical devices, including portable X-ray machine and ultrasonic diagnostic equipment; and extraporeal shockwave therapy and temperature control PROBE.
In addition, the company is involved in CDMO business; and research and development of Clopidogrel cardiovascular drug, Imatinlb anticancer drug, Donepezil anti-psychotic drug, Entecavir for anti-virus and infectious disease, and Esomeprazole.
It also exports its products. The company was formerly known as Kyongbo Chemical Co. Ltd. and changed its name to Kyongbo Pharmaceutical Co., Ltd in March 2002.
Kyongbo Pharmaceutical Co., Ltd was founded in 1987 and is headquartered in Asan-si, South Korea.
| Country | South Korea |
| Founded | 1987 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Tae-Young Kim |
Contact Details
Address: 174, Sirok-ro Asan-si South Korea | |
| Phone | 82 4 1420 0500 |
| Website | kbpharma.co.kr |
Stock Details
| Ticker Symbol | 214390 |
| Exchange | Korea Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7214390007 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Tae-Young Kim | Chief Executive Officer |